TLX
#1544
Telix Pharmaceuticals Limited - American Depositary Shares
11.2 9 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.79%
Changement Mensuel
+12.45%
Evolution sur 6 mois
+60.37%
Changement Annuel
+78.92%
Clôture Précédente
11.3 8
Open
11.2 9
Low
11.2 9
High
11.2 9
Volume
4
Financials
- Market Capitalization 3.82 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1534 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.74 USD | -6.56% | -10.09% | +76.43% | +277.61% | 3.87 B USD | ||
| 1542 |  DNLI Denali Therapeutics Inc. - Common Stock | 24.00 USD | -2.72% | -3.54% | 0.00% | +48.42% | 3.84 B USD | ||
| 1558 |  VKTX Viking Therapeutics, Inc. - Common Stock | 32.16 USD | -5.02% | -4.63% | -4.06% | +19.24% | 3.75 B USD | ||
| 1563 |  RCUS Arcus Biosciences, Inc. Common Stock | 29.19 USD | -4.61% | -4.30% | +6.46% | +176.42% | 3.72 B USD |